Concepedia
Statistics
Publications
26
Citations
928
H-Index
18
Active since
2015
Affiliations
Pfizer (United States)(Current)
Bristol-Myers Squibb (United States)
New York City College of Technology
Columbia University
City University of New York
Manuela Di Fusco is an author at Pfizer (United States) specializing in infectious diseases, medicine, and clinical pharmacology.
Publications per year
2015–2024
Health outcomes and economic burden of hospitalized COVID-19 patients in the United States
Manuela Di Fusco, Kimberly M. Shea, Jay Lin et al. · Journal of Medical Economics · 2021 · 217 citations · Full text
Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2
Manuela Di Fusco, Mary M. Moran, Alejandro Cané et al. · Journal of Medical Economics · 2021 · 57 citations · Full text
Medicine, Immunology, Infectious Diseases +13
Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients
Steven Deitelzweig, Allison Keshishian, Xiaoyan Li et al. · Journal of the American Geriatrics Society · 2019 · 54 citations · Full text
Pharmacy, Cardiology, Pharmacotherapy +17
Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study
Gregory Y.H. Lip, Allison Keshishian, Amiee Kang et al. · Journal of Internal Medicine · 2020 · 51 citations · Full text
Medicine, Cardiology, Pharmacotherapy +17
The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths
Teresa K. Yamana, Marta Galanti, Sen Pei et al. · PLoS ONE · 2023 · 46 citations · Full text
Public Affairs, Infectious Diseases, Preventive Medicine +16
1–5 of 26